[Treatment of rhythm disorders with aprindine. Results in 86 patients].
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D000814:Aniline Compounds / Q000008:administration & dosage; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy; D001282:Atrial Flutter / Q000188:drug therapy; D005117:Cardiac Complexes, Premature / Q000188:drug therapy; D004048:Diethylamines; D004562:Electrocardiography; D005260:Female; D006323:Heart Arrest / Q000139:chemically induced; D006325:Heart Atria; D006352:Heart Ventricles; D006801:Humans; D007189:Indans / Q000009:adverse effects / Q000627:therapeutic use*; D007192:Indenes / Q000627:therapeutic use*; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D013610:Tachycardia / Q000188:drug therapy; D014202:Tremor / Q000139:chemically induced; D014693:Ventricular Fibrillation / Q000188:drug therapy; D014717:Vertigo / Q000139:chemically induced; D014839:Vomiting / Q000139:chemically induced
D000814:Aniline Compounds; D000889:Anti-Arrhythmia Agents; D004048:Diethylamines; D007189:Indans; D007192:Indenes
Traitement des troubles du rythme par l'aprindine; Résultats sur 86 patients